Tavassoli, Fattaneh A.
Yale School of Medicine,
United States
2025 Rank: 276,956
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 372 out of 25,326 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 276,956 | 313,152 |
| Total Cites | 291 | 297 |
| H-index | 7 | 7 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 30 | 30 |
| Number of Single+First+Last Authored Papers | 192 | 192 |
| Total Cites to Single+First+Last Authored Papers | 197 | 197 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 256 | 260 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.14 |
| Self-Citation Percentage |
2.02%
|
|
Tavassoli, Fattaneh A.
Yale University,
United States
2024 Rank: 171,890
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 244 out of 24,457 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 171,890 | 199,158 |
| Total Cites | 349 | 358 |
| H-index | 8 | 8 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 34 | 34 |
| Number of Single+First+Last Authored Papers | 192 | 192 |
| Total Cites to Single+First+Last Authored Papers | 214 | 220 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 317 | 323 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.11 |
| Self-Citation Percentage |
2.51%
|
|
Tavassoli, Fattaneh A.
Yale School of Medicine,
United States
2023 Rank: 72,457
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 137 out of 23,576 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 72,457 | 82,152 |
| Total Cites | 490 | 495 |
| H-index | 9 | 9 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 23 | 23 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 64 | 64 |
| Number of Single+First+Last Authored Papers | 192 | 192 |
| Total Cites to Single+First+Last Authored Papers | 326 | 329 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 409 | 412 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.20 |
| Self-Citation Percentage |
1.01%
|
|
Tavassoli, Fattaneh A.
Yale School of Medicine,
United States
2022 Rank: 103,201
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 185 out of 23,010 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 103,201 | 113,660 |
| Total Cites | 390 | 400 |
| H-index | 8 | 9 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 14 | 14 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 46 | 46 |
| Number of Single+First+Last Authored Papers | 191 | 191 |
| Total Cites to Single+First+Last Authored Papers | 254 | 257 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 355 | 363 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.10 |
| Self-Citation Percentage |
2.50%
|
|
Tavassoli, Fattaneh A.
Yale School of Medicine,
United States
2021 Rank: 67,356
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 118 out of 22,656 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 67,356 | 74,637 |
| Total Cites | 655 | 673 |
| H-index | 10 | 11 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 38 | 38 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 91 | 91 |
| Number of Single+First+Last Authored Papers | 191 | 191 |
| Total Cites to Single+First+Last Authored Papers | 440 | 448 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 551 | 565 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.19 |
| Self-Citation Percentage |
2.67%
|
|
Tavassoli, Fattaneh A.
Yale School of Medicine,
United States
2020 Rank: 78,204
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 132 out of 19,713 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 78,204 | 92,892 |
| Total Cites | 473 | 481 |
| H-index | 9 | 9 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 21 | 21 |
| Total Cites to Single Authored Papers | 27 | 27 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 68 | 68 |
| Number of Single+First+Last Authored Papers | 191 | 191 |
| Total Cites to Single+First+Last Authored Papers | 306 | 308 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 418 | 425 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.13 |
| Self-Citation Percentage |
1.66%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.